45 related articles for article (PubMed ID: 32663667)
1. Development of sulfonamide-based Schiff bases targeting urease inhibition: Synthesis, characterization, inhibitory activity assessment, molecular docking and ADME studies.
Hamad A; Khan MA; Rahman KM; Ahmad I; Ul-Haq Z; Khan S; Shafiq Z
Bioorg Chem; 2020 Sep; 102():104057. PubMed ID: 32663667
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, in vitro urease inhibitory potential and molecular docking study of benzofuran-based-thiazoldinone analogues.
Taha M; Rahim F; Ullah H; Wadood A; Farooq RK; Shah SAA; Nawaz M; Zakaria ZA
Sci Rep; 2020 Jun; 10(1):10673. PubMed ID: 32606439
[TBL] [Abstract][Full Text] [Related]
3. Benzimidazolone-piperazine/triazole/thiadiazole/furan/thiophene conjugates: Synthesis, in vitro urease inhibition, and in silico molecular docking studies.
Güven O; Menteşe E; Emirik M; Sökmen BB; Akyüz G
Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300336. PubMed ID: 37612782
[TBL] [Abstract][Full Text] [Related]
4.
Hassan SA; Aziz DM; Abdullah MN; Bhat AR; Dongre RS; Hadda TB; Almalki FA; Kawsar SMA; Rahiman AK; Ahmed S; Abdellattif MH; Berredjem M; Sheikh SA; Jamalis J
J Biomol Struct Dyn; 2024 Apr; 42(7):3747-3763. PubMed ID: 37402503
[TBL] [Abstract][Full Text] [Related]
5. Novel Coumarin Derivatives as Potential Urease Inhibitors for Kidney Stone Prevention and Antiulcer Therapy: From Synthesis to In Vivo Evaluation.
Shahzadi K; Bukhari SM; Zaidi A; Wani TA; Jan MS; Zargar S; Rashid U; Farooq U; Khushal A; Khan S
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004418
[TBL] [Abstract][Full Text] [Related]
6. Designing and Synthesis of Novel Fexofenadine-Derived Hydrazone-Schiff bases as Potential Urease Inhibitors: In-Vitro, Molecular Docking and DFT Investigations.
Ayaz M; Alam A; Zainab Z; Elhenawy AA; Rehman NU; Rahman SU; Ali M; Latif A; Harrasi AA; Ahmad M
Chem Biodivers; 2024 May; ():e202400704. PubMed ID: 38781003
[TBL] [Abstract][Full Text] [Related]
7.
Khan S; Hussain R; Khan Y; Iqbal T; Anwar S; Aziz T; Alharbi M
Z Naturforsch C J Biosci; 2024 Apr; ():. PubMed ID: 38635830
[TBL] [Abstract][Full Text] [Related]
8. Discovering phenoxy acetohydrazide derivatives as urease inhibitors and molecular docking studies.
Taha M; Rahim F; Uddin I; Amir M; Iqbal N; Wadood A; Khan KM; Uddin N; Rehman AU; Farooq RK
J Biomol Struct Dyn; 2024 Apr; 42(6):3118-3127. PubMed ID: 37211867
[No Abstract] [Full Text] [Related]
9. Synthesis,
Khan Y; Maalik A; Rehman W; Alanazi MM; Khan S; Hussain R; Rasheed L; Saboor A; Iqbal S
Future Med Chem; 2024 Feb; 16(4):335-348. PubMed ID: 38314616
[No Abstract] [Full Text] [Related]
10. Biological Evaluation and Molecular Docking of Protocatechuic Acid from Hibiscus sabdariffa L. as a Potent Urease Inhibitor by an ESI-MS Based Method.
Hassan STS; Švajdlenka E
Molecules; 2017 Oct; 22(10):. PubMed ID: 29019930
[TBL] [Abstract][Full Text] [Related]
11. Exploration of morpholine-thiophene hybrid thiosemicarbazones for the treatment of ureolytic bacterial infections via targeting urease enzyme: Synthesis, biochemical screening and computational analysis.
Munir R; Zaib S; Zia-Ur-Rehman M; Javed H; Roohi A; Zaheer M; Fatima N; Bhat MA; Khan I
Front Chem; 2024; 12():1403127. PubMed ID: 38855062
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, anti-mycobacterial activity, molecular docking and ADME analysis of spiroquinoxaline-1,2,4-oxadiazoles via [3 + 2] cycloaddition reaction under ultrasound irradiation.
Kanchrana M; Gamidi RK; Kumari J; Sriram D; Basavoju S
Mol Divers; 2024 Jan; ():. PubMed ID: 38261121
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential drug candidates to treat gastritis and associated oxidative stress based on some novel 2-aryl-1
Sultana A; Wahab A; Fareed G; Rafiq H; Khan KM; Lateef M; Fareed N; Hussain S; Sherwani SK
RSC Adv; 2024 Jan; 14(1):529-537. PubMed ID: 38173575
[TBL] [Abstract][Full Text] [Related]
14. Urease inhibitory potential of pyridine-containing triazolothiadiazole and triazolothiadiazine scaffolds for the treatment of ulceration and kidney stone:
Ullah S; Halim SA; Ibrar A; Khan I; Ataya FS; Fouad D; Batiha GE; Khan A; Al-Harrasi A
J Biomol Struct Dyn; 2023 Dec; ():1-10. PubMed ID: 38153364
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, molecular docking, and molecular dynamic studies of novel quinazoline derivatives as phosphodiesterase 7 inhibitors.
El-Malah AA; Gineinah MM; Khayat MT; Aljahdali AS; Safar MM; Almazmumi HA; Khinkar RM
Front Pharmacol; 2024; 15():1389076. PubMed ID: 38711988
[No Abstract] [Full Text] [Related]
16. Exploring the Potential of New Benzamide-Acetamide Pharmacophore Containing Sulfonamide as Urease Inhibitors: Structure-Activity Relationship, Kinetics Mechanism, and In Silico Studies.
Ahmad S; Abdul Qadir M; Ahmed M; Imran M; Ahmad M; Yousaf N; Wani TA; Zargar S; Ali I; Muddassar M
ACS Omega; 2023 Dec; 8(48):46165-46181. PubMed ID: 38075833
[TBL] [Abstract][Full Text] [Related]
17. Rabbit muscle pyruvate kinase activators: Synthesis, molecular docking and theoretical studies of N-substituted sulfonamide derivatives.
Kaya MO; Demirci T; Musatat AB; Özdemir O; Sönmez F; Kaya Y; Arslan M
Int J Biol Macromol; 2024 Jun; 274(Pt 2):133184. PubMed ID: 38925176
[TBL] [Abstract][Full Text] [Related]
18. Schiff Bases: A Captivating Scaffold with Potential Anticonvulsant Activity.
Sahu R; Shah K
Mini Rev Med Chem; 2024 Apr; ():. PubMed ID: 38629363
[TBL] [Abstract][Full Text] [Related]
19. Different Schiff Bases-Structure, Importance and Classification.
Raczuk E; Dmochowska B; Samaszko-Fiertek J; Madaj J
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164049
[TBL] [Abstract][Full Text] [Related]
20. Current Perspectives on Biological Screening of Newly Synthetised Sulfanilamide Schiff Bases as Promising Antibacterial and Antibiofilm Agents.
Coanda M; Limban C; Draghici C; Ciobanu AM; Grigore GA; Popa M; Stan M; Larion C; Avram S; Mares C; Ciornei MC; Dabu A; Hudita A; Galateanu B; Pintilie L; Nuta DC
Pharmaceuticals (Basel); 2024 Mar; 17(4):. PubMed ID: 38675368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
